Cannablanca -
GACP practices
GMP compliance

KNOWLEDGE CENTER

30 March 2021
Medical By

The Benefits of Medical Cannabis: What the Science Says

Medical cannabis has become a subject of increasing global research, with clinical studies now exploring its therapeutic potential across a wide range of medical conditions. Although evidence continues to evolve, several areas show consistent scientific interest and growingclin cal support. 1:Pain Management Chronic pain—particularly neuropathic pain—remains one of the most studied indications.Cannabinoids may modulate pain perception by interacting with CB1

Read More
30 March 2021
Pharmaceutical By

Understanding CBD vs. THC: What’s the Difference?

Cannabis contains more than 140 cannabinoids, but CBD and THC remain the most widely recognized and studied. Although they originate from the same plant, their effects and interactions differ significantly. CBD (Cannabidiol): Non-Intoxicating Therapeutic Potential CBD does not produce intoxication. It interacts with multiple receptor systems—serotonergic, TRPV1, and others—rather than strongly binding to CB1 receptors like THC. Areas of scientific

Read More
30 March 2021
Economics By

Cannabis Around the World: A Global Snapshot

Medical cannabis is experiencing one of the fastest global regulatory shifts in contemporary healthcare. More than 50 countries now allow medical cannabis in some structured form, and many others are exploring controlled pilot programs. 1:Global Market Trends The legal cannabis market—including medical, wellness, and pharmaceutical segments—is projected to exceed USD 100 billion by 2030, driven by increased patient adoption, improved

Read More